Full Text
Comparative effectiveness, approval Rates and Pricing of Drugs with FDA’s breakthrough Therapy designations

Abstract

Authors

S. Aggarwal H. Topaloglu S. Kumar

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×